MetaCap

Aptevo Therapeutics (APVO) vs KALA BIO (KALA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

KALA BIO is the larger company by market cap ($1.7 million vs $1.4 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

APVO-78.04%KALA+651.39%
+1016%+443%-130%
Oct 7, 20261 yearNov 20, 2026
APVO-77.42%KALA+820.38%
+865%+371%-122%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

APVO versus KALA key metrics
MetricAPVOKALA
Share price$0.4041$2.71
Market cap$1.40M$1.74M
1-day change-2.37%-10.28%
P/E ratio (TTM)0.01—
EPS (TTM)$66.96$-321.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$0
Net income (latest FY)$-25.97M$-26.98M
52-week high$25.56$2,865.00
52-week low$0.377$2.65
Distance from 52-week high-98.42%-99.91%
Analyst consensusnone—
Avg. price target upside+6210.32%—
Average volume132.90K52.52K
Shares outstanding3.46M644.66K
Employees336
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Aptevo Therapeutics

APVO stock →

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.

Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees

About KALA BIO

KALA stock →

KALA BIO, Inc., a biopharmaceutical company, engages in the development of an on-premises artificial intelligence (AI) infrastructure platform for biotechnology research applications in the United States. The company develops Researgency, an agentic AI research platform for private enterprise AI deployment.

Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees

APVO vs KALA FAQ

Which is bigger, Aptevo Therapeutics or KALA BIO?

KALA BIO (KALA) is larger, with a market capitalization of $1.74M compared with $1.40M for Aptevo Therapeutics (APVO).

Are Aptevo Therapeutics and KALA BIO in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons